Asian Oncol Nurs.  2017 Sep;17(3):158-169. 10.5388/aon.2017.17.3.158.

Experience of Chemotherapy in Ovarian Cancer Patients

• Shin N
• Kim J

• KMID: 2392515
• DOI: http://doi.org/10.5388/aon.2017.17.3.158

Abstract

PURPOSE
The purpose of this study was to identify the experiences of patients with ovarian cancer undergoing chemotherapy
METHODS
A phenomenological method was used in this study. Data were collected by individual in-depth interviews with six participants with ovarian cancer undergoing chemotherapy during 2016. Colaizzi's phenomenology has been adopted as a research method in this qualitative study.
RESULTS
Seven theme clusters were derived from the data as follows: "˜Recognizing cancer diagnosis and treatment as braking in life,'"˜Effect on being a housewife as a cancer patient,'"˜Ambivalence about treatment,'"˜Fear with physical side effects,'"˜Losing sexuality as a woman,'"˜Affected by other ovarian cancer patients,'"˜Practice hope after treatment.'
CONCLUSION
Patients with ovarian cancer experienced tremendous physical and psychosocial problems. This finding demonstrates the need to develop appropriate nursing interventions for issues related to the experience of patients with ovarian cancer receiving chemotherapy.

Keyword

Drug Therapy; Ovarian Neoplasms; Patients; Qualitative Research

MeSH Terms

Diagnosis
Drug Therapy*
Hope
Humans
Methods
Nursing
Ovarian Neoplasms*
Qualitative Research
Sexuality

Reference

1. Ministry of Health and Welfare(KR); National Cancer Center (KR). Cancer facts & figures 2016 in the Republic of Korea. Sejong: Ministry of Health and Welfare;2016.

2. Oh CM, Won YJ, Jung KW, Kong HJ, Cho H, Lee JK, et al. Cancer statistics in Korea: incidence, mortality, survival, and prevalence in 2013. Cancer Res Treat. 2016; 48:436–50.

3. Kim SC. Recent advances in ovarian cancer treatment. J Korean Med Assoc. 2016; 59:164–6.

4. Siegel RL, Miller KD, Jemal A. Cancer statistics, 2016. CA Cancer J Clin. 2016; 66:7–30.

5. Chang SJ. Surgical management of ovarian cancer. J Korean Med As-soc. 2016; 59:167–74.

6. Lim MC, Park SY. Chemotherapy for ovarian cancer. J Korean Med As-soc. 2016; 59:175–9.

7. Meraner V, Gamper EM, Grahmann A, Giesinger JM, Wiesbauer P, Sz-tankay M, et al. Monitoring physical and psychosocial symptom trajec-tories in ovarian cancer patients receiving chemotherapy. BMC Cancer. 2012; 12:77.

8. Penar-Zadarko B, Binkowska-Bury M, Wolan M, Gawelko J, Urbanski K. Longitudinal assessment of quality of life in ovarian cancer patients. Eur J Oncol Nurs. 2013; 17:381–5.

9. Ezendam NP, Pijlman B, Bhugwandass C, Pruijt JF, Mols F, Vos MC, et al. Chemotherapy-induced peripheral neuropathy and its impact on health-related quality of life among ovarian cancer survivors: results from the population-based PROFILES registry. Gynecol Oncol. 2014; 135:510–7.

10. Hopkins TG, Stavraka C, Gabra H, Fallowfield L, Hood C, Blagden S. Sexual activity and functioning in ovarian cancer survivors: an inter-net-based evaluation. Climacteric. 2015; 18:94–8.

11. Hwang KH, Cho OH, Yoo YS. Symptom clusters of ovarian cancer patients undergoing chemotherapy, and their emotional status and quality of life. Eur J Oncol Nurs. 2016; 21:215–22.

12. Kim K, Lee M, Kwak Y, Kim JS. Factors affecting the fatigue of hospitalized women cancer patients receiving chemotherapy. Asian Oncol Nurs. 2014; 14:182–90.

13. Lee ES, Park JS. The comparison of health promotion behavior, post traumatic growth and quality of life according to stages of survivorship in patients with female genital neoplasm. Korean J Adult Nurs. 2013; 25:312–21.

14. Nho JH, Kim SR, Kang GS, Kwon YS. Relationships among malnutri-tion, depression and quality of life in patients with gynecologic cancer receiving chemotherapy. Korean J Women Health Nurs. 2014; 20:117–25.

15. Yu SY, Nho JH. Influence of sleep disturbance and depression on quality of life in ovarian cancer patients during chemotherapy. Asian Oncol Nurs. 2015; 15:203–10.

16. Espinosa PP, Espinosa MJ. Experiences to chemotherapy among women with breast cancer. Int J Bio Sci Bio Technol. 2016; 8:159–66.

17. Park JA. The experienced of chemotherapy before stem cell transplan-tation in patients with hematologic malignancy. Qual Res. 2015; 16:34–47.

18. Colaizzi PE. Psychological research as the phenomenologist views it. New York, NY: Oxford University Press;1978.

19. Lincoln YS, Guba EG. Naturalistic inquiry. Newbury Park, CA: SAGE Publications. 1985.

21. DellaRipa J, Conlon A, Lyon DE, Ameringer SA, Lynch Kelly D, Men-zies V. Perceptions of distress in women with ovarian cancer. Oncol Nurs Forum. 2015; 42:292–300.

22. Witham G, Haigh C, Foy S. The challenges of health professionals in meeting the needs of vulnerable patients undergoing chemotherapy: a focus group study. J Clin Nurs. 2014; 23:2844–53.

23. Spichiger E, Rieder E, Müller-Fröhlich C, Kesselring A. Fatigue in patients undergoing chemotherapy, their self-care and the role of health professionals: a qualitative study. Eur J Oncol Nurs. 2012; 16:165–71.

24. Heo SM, Heo N. Experiences of self-management support among breast cancer survivors. Korean J Adult Nurs. 2016; 28:470–81.

25. Moradian S, Howell D. Prevention and management of chemotherapy-induced nausea and vomiting. Int J Palliat Nurs. 2015; 21:216–24.

26. Farrell C, Brearley SG, Pilling M, Molassiotis A. The impact of chemotherapy-related nausea on patients’ nutritional status, psychological distress and quality of life. Support Care Cancer. 2013; 21:59–66.

27. Olver I, Molassiotis A, Aapro M, Herrstedt J, Grunberg S, Morrow G. Antiemetic research: future directions. Support Care Cancer. 2011; 19.

28. List⊘l W, H⊘berg-Vetti H, Eide GE, Bjorvatn C. Anxiety and depression symptoms among women attending group-based patient education courses for hereditary breast and ovarian cancer. Hered Cancer Clin Pract. 2017; 15:2.

29. Gaston-Johansson F, Haisfield-Wolfe ME, Reddick B, Goldstein N, La-wal TA. The relationships among coping strategies, religious coping, and spirituality in African American women with breast cancer receiving chemotherapy. Oncol Nurs Forum. 2013; 40:120–31.